Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Shares withheld for taxes Huang Dennis Karl gave up 1,348 shares (to pay taxes)
  2. 4 Open-market sale SVP, Chief Accounting Officer sold 967 shares at $42.10 ($40,711)
  3. 4 Grant or award Chief Financial Officer acquired 15,653 shares (grant or award)
  4. 4 Open-market sale EVP and Chief Legal Officer sold 2,990 shares at an average $42.88 ($128,224)
  5. 4 Planned sale President & CEO sold 11,727 shares at $42.23 ($495,231)
  6. 4 Gift SVP, Chief Accounting Officer gave 648 shares (gift)
  7. 4 Planned sale President & CEO sold 8,273 shares at $50.00 ($413,650)
  8. 4 Open-market sale Chief Financial Officer sold 7,465 shares at $52.76 ($393,853)
  9. 4 Grant or award SVP, Chief Accounting Officer acquired 700 shares (grant or award)
  10. 4 Planned sale President & CEO sold 20,000 shares at $55.85 ($1,117,000)
  11. 4 Open-market sale SVP, Chief Accounting Officer sold 91 shares at $56.19 ($5,113)
  12. 4 Planned sale President & CEO sold 20,000 shares at $50.17 ($1,003,400)
  13. 4 Planned sale Director sold 584 shares at $40.98 ($23,932)
  14. 4 Grant or award Director acquired 5,345 shares (grant or award)
  15. 4 Grant or award Director acquired 5,345 shares (grant or award)
  16. 4 Grant or award Director acquired 5,345 shares (grant or award)
  17. 4 Grant or award Director acquired 5,345 shares (grant or award)
  18. 4 Grant or award Director acquired 5,345 shares (grant or award)
  19. 4 Grant or award Director acquired 5,345 shares (grant or award)
  20. 4 Grant or award Director acquired 5,345 shares (grant or award)

Page 4 of 32 · 627 filings